Li-Ching Lee Selected Research

TATA-Box Binding Protein (TATA-Binding Protein)

12/2014	Deactivation of TBP contributes to SCA17 pathogenesis.
6/2014	Downregulation of proteins involved in the endoplasmic reticulum stress response and Nrf2-ARE signaling in lymphoblastoid cells of spinocerebellar ataxia type 17.
1/2014	Role of high mobility group box 1 (HMGB1) in SCA17 pathogenesis.
1/2012	Role of the CCAAT-binding protein NFY in SCA17 pathogenesis.
3/2010	SCA17 repeat expansion: mildly expanded CAG/CAA repeat alleles in neurological disorders and the functional implications.
2/2009	Altered expression of HSPA5, HSPA8 and PARK7 in spinocerebellar ataxia type 17 identified by 2-dimensional fluorescence difference in gel electrophoresis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Li-Ching Lee Research Topics

Disease

8	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 12/2014 - 03/2010
7	Autism Spectrum Disorder 01/2022 - 06/2013
7	Autistic Disorder (Autism) 01/2019 - 11/2006
4	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2022 - 12/2017
3	Neurodevelopmental Disorders 01/2021 - 03/2007
3	Huntington Disease (Huntington's Disease) 12/2014 - 01/2013
3	Parkinson Disease (Parkinson's Disease) 01/2014 - 03/2010
2	Neuroblastoma 01/2019 - 01/2016
2	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 06/2014 - 01/2013
2	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2014 - 01/2013
2	Spinocerebellar Ataxia 17 01/2012 - 02/2009
1	Asthma (Bronchial Asthma) 01/2022
1	Allergic Rhinitis 01/2022
1	Atopic Dermatitis (Atopic Eczema) 01/2022
1	Wounds and Injuries (Trauma) 10/2019
1	Developmental Disabilities (Developmental Disability) 01/2019
1	Cerebellar Ataxia (Dysmetria) 12/2014
1	Retinal Degeneration 12/2014
1	Mitochondrial Diseases (Mitochondrial Disease) 06/2014
1	Atrophy 06/2014
1	Starvation 01/2014
1	Nervous System Diseases (Neurological Disorders) 01/2013
1	Neuroinflammatory Diseases 01/2013
1	Mitral Valve Insufficiency (Mitral Regurgitation) 12/2012
1	ST Elevation Myocardial Infarction 12/2012
1	Parkinsonian Disorders (Parkinsonism) 03/2010
1	Alzheimer Disease (Alzheimer's Disease) 03/2010
1	Myocardial Infarction 06/2009
1	Obstructive Sleep Apnea 06/2009
1	Fever (Fevers) 12/2007
1	Schizophrenia (Dementia Praecox) 09/2004

Drug/Important Bio-Agent (IBA)

8	polyglutamineIBA 01/2016 - 01/2012
6	Proteins (Proteins, Gene)FDA Link 01/2016 - 03/2007
6	TATA-Box Binding Protein (TATA-Binding Protein)IBA 12/2014 - 02/2009
5	tributyl phosphate (TBP)IBA 12/2014 - 02/2009
3	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2021 - 06/2013
2	sulforaphaneIBA 06/2021 - 01/2021
2	Opioid Analgesics (Opioids)IBA 01/2019 - 01/2019
2	HDL LipoproteinsIBA 01/2018 - 12/2017
2	Peptide Initiation Factors (Initiation Factor)IBA 01/2014 - 03/2010
1	diazonaphthalenedisulfonic acid (NDS)IBA 01/2022
1	isothiocyanic acidIBA 01/2021
1	Analgesics (Analgesic Drugs)IBA 10/2019
1	Local AnestheticsIBA 10/2019
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2019
1	Acetaminophen (Paracetamol)FDA LinkGeneric 07/2018
1	Biomarkers (Surrogate Marker)IBA 07/2018
1	CholesterolIBA 12/2017
1	Triglycerides (Triacylglycerol)IBA 12/2017
1	TriazolesIBA 01/2016
1	di- tert- butylperoxy- 3,3,5- trimethylcyclohexane peroxide (BBTC)IBA 12/2014
1	indoleIBA 10/2014
1	Mutant Proteins (Protein, Mutant)IBA 06/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2014
1	Pharmaceutical PreparationsIBA 01/2014
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2014
1	HMGB1 Protein (HMG1)IBA 01/2014
1	Neurotransmitter Agents (Neurotransmitter)IBA 06/2013
1	Serotonin (5 Hydroxytryptamine)IBA 06/2013
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2013
1	Minocycline (Cyclops)FDA LinkGeneric 01/2013
1	peoniflorinIBA 01/2013
1	Biological ProductsIBA 12/2007
1	AutoantibodiesIBA 03/2007
1	AntibodiesIBA 03/2007
1	AntigensIBA 03/2007
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2006
1	HLA-DR4 Antigen (HLA DR4 Antigen)IBA 11/2006
1	Dopamine (Intropin)FDA LinkGeneric 09/2004

Therapy/Procedure

2	Therapeutics 10/2015 - 12/2012
1	Thrombolytic Therapy 12/2012
1	Deep Brain Stimulation 01/2012
1	Percutaneous Coronary Intervention 06/2009